ImmuCell Announces Unaudited Financial Results for the

22.02.2022 - Annual Product Sales for 2021 Increased 25% over 2020PORTLAND, Maine, Feb. 22, 2022 (GLOBE NEWSWIRE) - ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets ...

Related Keywords

Joe Dorame , Robert Blum , Michaelf Brigham , Joe Diaz , Exchange Commission , Lytham Partners , Immucell Corporation Nasdaq , Securities Exchange , Immucell Corporation , First Defense , Technical Sections , Controls Technical , Financial Results , Sheet Data , Corporate Presentation , Cell Corporation , Immediate Immunity , Years Ended December , Balance Sheet Data , Before Interest , Note Regarding Forward Looking Statements , Safe Harbor Statement , Press Release , Securities Act , Securities Exchange Act , Good Manufacturing Practice , Nisin Drug Substance , Drug Product , Quarterly Reports , Annual Reports , Current Reports ,